Abstract PS2-02-06: Benefit of adjuvant chemotherapy for early-stage hormone receptor positive and HER2 negative lobular breast cancer patients: Analysis based on genomic risk scores

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2026-02-17
DOI
https://doi.org/10.1158/1557-3265.sabcs25-ps2-02-06
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract PS2-02-06: Benefit of adjuvant chemotherapy for early-stage hormone receptor positive and HER2 negative lobular breast cancer patients: Analysis based on genomic risk scores

Stephen Myers, Margaret E. Gatti‐Mays, Dionisia Quiroga, Gilbert Bader et al.
Clinical Cancer Research
Breast Cancer Treatment Studies
article

Abstract PS2-02-06: Benefit of adjuvant chemotherapy for early-stage hormone receptor positive and HER2 negative lobular breast cancer patients: Analysis based on genomic risk scores

Stephen Myers, Margaret E. Gatti‐Mays, Dionisia Quiroga, Gilbert Bader, Ashley Pariser Davenport, Emily Burke, Brandon Slover, A. M. Roy, S. D. Sardesai, M. A. Cherian, N. Williams, Y. Gokun, R. Wesolowski, N. Lopetegui-Lia, K. Johnson, D. G. Stover
article en

Abstract

No abstract available for this paper.
Clinical Cancer ResearchVol. 32(4_Supplement)
The Ohio State University (US)
Good health and well-being
Openalex Percentile: Top 51%
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.